C-Reactive Protein Augments Interleukin-8 Secretion in Human Peripheral Blood Monocytes
- 1 November 2005
- journal article
- research article
- Published by Ovid Technologies (Wolters Kluwer Health) in Journal of Cardiovascular Pharmacology
- Vol. 46 (5), 690-696
- https://doi.org/10.1097/01.fjc.0000183568.48389.a1
Abstract
C-reactive protein (CRP) is a powerful predictor and risk factor for cardiovascular diseases. The CXC- and CC-type chemokines interleukin-8 (IL-8) and monocyte chemoattractant protein-1 (MCP-1) are important chemokines for leukocyte trafficking identified in atheromatous plaque expressed mainly by macrophages in humans. We assessed whether C-reactive protein could induce MCP-1 and IL-8 secretion. In human peripheral blood monocytes, C-reactive protein (12.5-50 μg/mL) increased IL-8, but not MCP-1 secretion in a time- (6-24 hours) and dose-dependent manner as detected by ELISA. C-reactive protein could augment the production of reactive oxygen species (ROS) as measured by chemiluminescence and inhibitors of NAD(P)H oxidase (DPI and PAO) and ROS scavengers (superoxide dismutase, catalase, and 1% dimethyl sulphoxide) abolished C-reactive protein-induced IL-8 secretion. Furthermore, relative quantity of IL-8 mRNA was significantly increased by C-reactive protein 50 μg/mL for 12 hours, which could be inhibited by DPI 1 μM or superoxide dismutase (SOD) 250 U/mL. The inhibitors of ERK 1/2 (PD98059), p38 (SB203580) MAPK, and NF-κB (PDTC and MG132) significantly decreased C-reactive protein-induced IL-8 secretion in human monocytes. Also, agonists of peroxisome proliferator-activated receptor (PPAR) α (WY14643) and PPARγ (troglitazone) could largely inhibit C-reactive protein responses. Thus, our data indicate that C-reactive protein at pathologic levels increases IL-8 secretion and mRNA via enhancing ROS derived mainly from NAD(P)H oxidase and the subsequent activation of ERK1/2, p38 MAPK, and NF-κB. The activation of PPARα/γ can negatively regulate C-reactive protein-induced IL-8 production in human monocytes.Keywords
This publication has 41 references indexed in Scilit:
- Modulation of Atherogenesis by ChemokinesTrends in Cardiovascular Medicine, 2004
- Chemokines and atherosclerosisAnnals of Medicine, 2004
- Elevated Levels of C-Reactive Protein at Discharge in Patients With Unstable Angina Predict Recurrent InstabilityCirculation, 1999
- Atherosclerosis — An Inflammatory DiseaseNew England Journal of Medicine, 1999
- Prospective Study of C-Reactive Protein and the Risk of Future Cardiovascular Events Among Apparently Healthy WomenCirculation, 1998
- Predictive value of C-reactive protein after successful coronary-artery stenting in patients with stable anginaThe American Journal of Cardiology, 1998
- Inflammation, Aspirin, and the Risk of Cardiovascular Disease in Apparently Healthy MenNew England Journal of Medicine, 1997
- Interleukin-8 Production by Macrophages From Atheromatous PlaquesArteriosclerosis, Thrombosis, and Vascular Biology, 1996
- The Prognostic Value of C-Reactive Protein and Serum Amyloid A Protein in Severe Unstable AnginaNew England Journal of Medicine, 1994
- Monocyte chemoattractant protein-1 in human atheromatous plaques.JCI Insight, 1991